Advice on Vaccinations provided by NIAC to the Department of Health

The National Immunisation Advisory Committee (NIAC) provides evidence-based advice to the Department of Health on vaccinations.

2022

• Recommendations for the use of Monkeypox Modified Vaccinia Ankara Vaccines, Imvanex or Jynneos, by the intradermal route
  Issued 22 August 2022

• Letter to the Interim Chief Medical Officer re: Recommendations for the use of smallpox (vaccinia) vaccine as pre and post exposure prophylaxis against monkeypox
  Issued 22 July 2022

• Recommendations for additional COVID-19 Booster Vaccination
  Issued 22 July 2022

• Recommendations for Monkeypox Vaccination
  Issued 27 May 2022

• Updated recommendations for HPV Vaccination
  Issued 14 April 2022

• Medium Term Strategy for the COVID-19 Vaccination Programme including Second Booster Dose
  Issued 05 April 2022

• Recommendations for COVID-19 booster vaccination of those aged 12-15 years
  Issued 18 February 2022

• Letter to the Chief Medical Officer re: recommendations for Nuvaxovid COVID-19 vaccine (Novavax)
  Issued 27 January 2022

2021

• Final letter to the Chief Medical Officer re: interval between laboratory-confirmed breakthrough infection and
  an additional or booster COVID-19 vaccination
  Issued 21 December 2021

• Letter to the Chief Medical Officer re: Waiver of 15-minute observation period post booster COVID-19 mRNA vaccine
  Issued 15 December 2021

• Letter to the Chief Medical Officer re: recommendations for booster interval, and booster vaccination for those with immunocompromise associated with a suboptimal response to vaccines
  Issued 13 December 2021

• Recommendations on COVID-19 vaccination for children aged 5 to 11 Years
  Issued 07 December 2021

• Recommendations on booster doses of COVID-19 vaccine for those aged 16-49 years
  Issued 25 November 2021 | Updated 26 November 2021

• Recommendations on booster doses of COVID-19 vaccine for healthcare workers, 16-59 years with underlying conditions, and all those 50-59 years
  Issued 15 November 2021

• Updated recommendations regarding selection, dose and timing of booster doses of COVID-19 vaccine for those aged 60 years and over
  Issued 03 November 2021

• An Overview of Recommendations regarding booster doses of COVID-19 Vaccine for Healthcare Workers
  Issued 01 November 2021

• NIAC Recommendations regarding booster doses of COVID-19 Vaccine for those aged 60 to 79 years
  Issued 22 October 2021

• NIAC Overview of Recommendations regarding booster doses of COVID-19 Vaccine for those aged 60 to 79 years
  Issued 18 October 2021

• Immunisation Guidelines on COVID-19 Vaccine - Chapter 5a
  Updated 15 October 2021

• Interim recommendations regarding booster doses of COVID-19 Vaccine for those aged 80 years and older, and those aged 65 and older in long term care facilities
  Issued 07 September 2021

• Recommendations regarding an additional COVID-19 Vaccine dose for those with immunocompromise associated with a suboptimal response to vaccines
  Issued 30 August 2021

• Updated Recommendations for COVID-19 Vaccination in Pregnancy
  Issued 30 August 2021 | Amended 02 September 2021

• Recommendations for the role of COVID-19 heterologous vaccination in the national programme
  Issued 15 July 2021

• Recommendations on COVID-19 Vaccination for those aged 12-15 years
  Issued 26 July 2021

• Letter to the Chief Medical Officer re: NIAC advice on the potential role of heterologous vaccination and the potential ongoing role of viral vector vaccines as part of the COVID-19 vaccination programme in Ireland
  Issued 28 June 2021

• Recommendations for the second COVID-19 Vaccine dose for those who have already had a first dose of Vaxzevria®
  Published 31 May 2021

• Letter to the Chief Medical Officer about COVID-19 vaccine related issues under consideration
  Issued 24 May 2021

• Recommendations regarding Adenoviral Vector Vaccines
  Published 13 May 2021

• COVID-19 Vaccination after Laboratory confirmed COVID-19 Infection
  Published 26 April 2021 | Updated 29 April 2021

• Recommendations for the use of COVID-19 Vaccines: COVID-19 Vaccine Janssen | Vaxzevria COVID-19 Vaccine AstraZeneca | mRNA Vaccine dose interval
  Published 26 April 2021 | Updated 29 April 2021

• Letter to the Chief Medical Officer about NIAC Recommendations re COVID-19 vaccination
  Issued 29 April 2021

• Recommendations for COVID-19 vaccination in pregnancy
  Published 26 April 2021

• Recommendations for the use of Vaxzevria® COVID-19 Vaccine AstraZeneca
  Published 12 April 2021

• Updated Recommendations: Priority Groups for COVID-19 Vaccination
  Published 29 March 2021

• Recommendations for the use of COVID-19 Vaccine AstraZeneca®
  Published 19 March 2021

• Updated Recommendations for the use of COVID-19 Vaccines
  Published 10 March 2021

• Recommendations for the COVID-19 Vaccination Programme for those aged 65-69 years
  Published 23 February 2021

• Updated Recommendations: Priority Groups for COVID-19 Vaccination
  Published 22 February 2021

• Recommendations for the use of COVID-19 vaccine AstraZeneca® in Ireland
  Published 3 February 2021

• Letter to Chief Medical Officer about Notifications to Norwegian Health Authorities relating to the possible impact of COVID-19 mRNA vaccines on mortality in the frail elderly
  Issued 15 January 2021

2020

• NIAC Recommendations for COVID-19 Vaccine Rollout
  Published 21 December 2020

• Email to Chief Medical Officer and Deputy Chief Medical Officer about initial vaccine rollout and vaccine recommendations
  Issued 17 December 2020

• Priority groups SARS-CoV-2 vaccine
  Published 2 November 2020